Jump to content

Jo Douglass

From Wikipedia, the free encyclopedia
(Redirected from Jo Anne Douglass)
Jo A. Douglass
NationalityAustralia
EducationMonash University
OccupationHealth researcher
EmployerRoyal Melbourne Hospital
Known forAsthma and Allergy research
TitleProfessor
Websitehttps://findanexpert.unimelb.edu.au/profile/32737-jo-douglass

Jo A. Douglass or Jo Anne Douglass is an Australian asthma researcher, Director of Research within the Royal Melbourne Hospital, James Stewart Professor of Medicine and she is also Department Head of Medicine within the Melbourne Medical School. She was awarded an Order of Australia,[1] for her "distinguished service to medical research, to clinical immunology and allergy, to respiratory medicine, and to tertiary education."[2]

Education and career

[edit]

Douglass received her undergraduate degree, in Medical Science, and Bachelor of Medicine and Bachelor of Surgery at Monash University, and subsequently completed postgraduate education in London.[3] She was the president of the Australasian Society of Clinical Immunology and Allergy from 2010 to 2012,[4] as well as a member of the European Respiratory Society.[5]

At the Royal Melbourne Hospital, Douglass was the head of Department of Immunology and Allergy.[6] She specialises in the clinical and research of both asthma and allergic disease, at Royal Melbourne Hospital.[7]

Douglass's research is centered around the clinical and research of asthma and allergies, including thunderstorm asthma, diagnosis using genomic medicine, as well as immune deficiencies.[8]

Publications

[edit]

Douglass has an H-index of 43, according to Google Scholar,[9] and more than 100 publications as at July 2024.[10][11] Select examples include:

  • Holgate ST, Douglass JA (eds) (2013) Fast Facts: Asthma. Health Press Ltd, Oxford UK. 2013[12]
  • Chua JC, Douglass JA, et al. (2012) Galectin-10, a Potential Biomarker of Eosinophilic Airway Inflam. PLoS ONE 7(8): e42549.[13]
  • Thompson BR, Douglass JA, et al. (2013) Peripheral Lung Function in patients with ... asthma. Jour of Allergy and Clin Immunology 2013; 131: P1322-1328.[14]
  • Chen Y, Stirling R, Hore-Lacy F, Thompson B, Douglass JA. (2011) Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies. J Allergy Clinical Immunolology. 127: P1414-7.[15]
  • Douglass, et al. (2012) Over-the-counter β2-agonist purchase vs script: a cross-sectional study. Respiritory Med. 106(2):P 223–9.[16]
  • Gillman A, Douglass JA. (2010) What do asthmatics have to fear from food and additive allergy? Clinical Exp Allergy 40: P1295-1302.[17]
  • O'Hehir RE, Gardner LM, de Leon MP, Hales BJ, Biondo M, Douglass JA, et al.. (2009) House dust mite immunotherapy: the role for transforming growth factor-beta and ... T cells. Am Journal of Respir Critical Care Med 80: P936-47.[18]

Awards

[edit]
[edit]

References

[edit]
  1. ^ "Governor General" (PDF).
  2. ^ Chung, J.; Shin, K.; Lee, K. (2006). "Effect of Feedback Education of a Respiratory Service Program(RSP) on Inhaler". Journal of Allergy and Clinical Immunology. 117 (2): S192. doi:10.1016/j.jaci.2005.12.761. ISSN 0091-6749.
  3. ^ "Uni Melbourne". findanexpert.unimelb.edu.au.
  4. ^ "ASCIA Committees and Working Parties – Australasian Society of Clinical Immunology and Allergy (ASCIA)". www.allergy.org.au. Retrieved 2024-07-20.
  5. ^ "Uni Melbourne". findanexpert.unimelb.edu.au. Retrieved 2024-07-20.
  6. ^ "Meet the Team – AusPIPS Advisory panel". www.auspips.org.au. Retrieved 2024-07-20.
  7. ^ "Prof Jo Douglass | Melbourne Allergy Asthma & Immunology Specialists". Melbourne Allergy Asthma & Immunology Consultants. Retrieved 2024-07-20.
  8. ^ "Meet the Team – AusPIPS Advisory panel". www.auspips.org.au. Retrieved 2024-07-20.
  9. ^ "Jo Douglass". scholar.google.com.au. Retrieved 2024-07-20.
  10. ^ "Prof Jo Douglass | Melbourne Allergy | Parkville Allergy Asthma & Immunology". Parkville Allergy Asthma & Immunology Consultants. Retrieved 2024-07-20.
  11. ^ Chatelier, Josh; Chan, Samantha; Tan, Ju Ann; Stewart, Alastair G.; Douglass, Jo Anne (2021-09-08). "Managing Exacerbations in Thunderstorm Asthma: Current Insights". Journal of Inflammation Research. 14: 4537–4550. doi:10.2147/JIR.S324282. hdl:11343/287930. PMC 8436255. PMID 34526800.
  12. ^ "Fast Facts: Asthma | Books Gateway | Karger Publishers". www.karger.com. Retrieved 2024-07-20.
  13. ^ Thompson, Bruce R.; Douglass, Jo A.; Ellis, Matthew J.; Kelly, Vanessa J.; O'Hehir, Robyn E.; King, Gregory G.; Verbanck, Sylvia (2013). "Peripheral lung function in patients with stable and unstable asthma". The Journal of Allergy and Clinical Immunology. 131 (5): 1322–1328. doi:10.1016/j.jaci.2013.01.054. ISSN 1097-6825. PMID 23561802.
  14. ^ Chua, Justin C.; Douglass, Jo A.; Gillman, Andrew; O'Hehir, Robyn E.; Meeusen, Els N. (2012). "Galectin-10, a potential biomarker of eosinophilic airway inflammation". PLOS ONE. 7 (8): e42549. Bibcode:2012PLoSO...742549C. doi:10.1371/journal.pone.0042549. ISSN 1932-6203. PMC 3412795. PMID 22880030.
  15. ^ Chen, Yan; Stirling, Rob G.; Paul, Eldho; Hore-Lacy, Fiona; Thompson, Bruce R.; Douglass, Jo A. (2011). "Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies". The Journal of Allergy and Clinical Immunology. 127 (6): 1414–1417. doi:10.1016/j.jaci.2011.03.041. ISSN 1097-6825. PMID 21546068.
  16. ^ Douglass, Jo A.; Goeman, Dianne P.; McCarthy, Edwina A.; Sawyer, Susan M.; Aroni, Rosalie A.; Stewart, Kay; Abramson, Michael J. (2012). "Over-the-counter β2-agonist purchase versus script: a cross-sectional study". Respiratory Medicine. 106 (2): 223–229. doi:10.1016/j.rmed.2011.09.012. ISSN 1532-3064. PMID 22040532.
  17. ^ Gillman, A.; Douglass, Jo A. (2010). "What do asthmatics have to fear from food and additive allergy?". Clinical and Experimental Allergy. 40 (9): 1295–1302. doi:10.1111/j.1365-2222.2010.03528.x. ISSN 1365-2222. PMID 20528881.
  18. ^ O'Hehir, Robyn E.; Gardner, Leanne M.; de Leon, Maria P.; Hales, Belinda J.; Biondo, Mark; Douglass, Jo A.; Rolland, Jennifer M.; Sandrini, Alessandra (2009-11-15). "House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells". American Journal of Respiratory and Critical Care Medicine. 180 (10): 936–947. doi:10.1164/rccm.200905-0686OC. ISSN 1535-4970. PMID 19696440.
  19. ^ Physicians, The Royal Australasian College of, The Royal Australasian College of Physicians, The Royal Australasian College of Physicians, retrieved 2024-07-20
  20. ^ "Fellow of TSANZ". The Thoracic Society of Australia & New Zealand. Retrieved 2024-07-20.